15 January 2026· Updated 01 May 2026

Ozempic in Australia 2026: What You Actually Need to Know

Key Takeaways

Ozempic (semaglutide) is registered by the TGA for type 2 diabetes — but millions of Australians are using it for weight loss. Here's the complete, accurate guide for 2026.

What Is Ozempic and Why Is Everyone Talking About It?

Ozempic is the brand name for semaglutide, a weekly injectable medication made by Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists — medications that mimic a natural gut hormone to regulate appetite, slow digestion, and improve blood sugar control. In Australia, Ozempic is registered by the Therapeutic Goods Administration (TGA) for the treatment of type 2 diabetes in adults.

Over the past three years, Ozempic became a cultural phenomenon well beyond diabetes management. Sustained clinical trial data showed that people taking semaglutide lost significant body weight — far more than with older weight loss medications — and demand for the drug exploded globally. In Australia, this created shortages throughout 2022 and 2023 and generated enormous media coverage. That coverage was not always accurate.

This guide is written for Australians who want accurate, current information about Ozempic in 2026 — what it is, what it does, who can access it, what it costs, and how it compares to the alternatives now available.

Is Ozempic Approved for Weight Loss in Australia?

This is the most common source of confusion. Ozempic itself is not TGA-approved for weight loss. Its TGA-registered indication is the management of type 2 diabetes in adults.

However, Australian GPs are legally permitted to prescribe any registered medication for an off-label use — that is, for a purpose other than its registered indication — when they judge it to be clinically appropriate. This is a standard, legal, and very common practice in Australian medicine.

This means that a GP can prescribe Ozempic to a patient without type 2 diabetes for the purpose of weight management, provided they assess it as appropriate for that patient's clinical situation.

The drug specifically registered for weight management in Australia is Wegovy — which contains the same active ingredient (semaglutide) but at a higher maintenance dose of 2.4mg, compared to Ozempic's maximum dose of 2mg.

Ozempic vs Wegovy: Same Drug, Different Situation

Wegovy and Ozempic both contain semaglutide. The practical differences are:

Dose: Wegovy reaches a maintenance dose of 2.4mg/week. Ozempic's maximum approved dose is 2mg/week (though 1mg is the most commonly prescribed dose for diabetes).
Indication: Wegovy is TGA-registered for chronic weight management. Ozempic is registered for type 2 diabetes.
Price: Both are private prescription medications for weight loss purposes, meaning neither is PBS-subsidised for weight management. Costs are broadly comparable.
Availability: Supply has stabilised significantly since 2023. Both are generally available through pharmacies in 2026, though stock can vary.

For most patients seeking weight loss, a GP may prescribe either, depending on their assessment of clinical appropriateness, the patient's history, and the dose required.

How Does Ozempic Cause Weight Loss?

Semaglutide mimics GLP-1, a hormone naturally released by the gut after eating. Elevated GLP-1 levels do several things relevant to weight:

Want to discuss Ozempic with a GP?

Our GPs bulk bill all weight management consultations through Medicare. Assess your options from home — no referral needed.

Request an Appointment

Signal satiety to the brain — reducing hunger and food cravings
Slow gastric emptying — meaning food stays in the stomach longer, sustaining fullness
Reduce the reward-seeking behaviour associated with high-calorie foods in some patients

The result, in clinical trials, was significant and sustained weight loss. The SUSTAIN and STEP trial programs showed mean weight reductions of 5–15% depending on dose and duration. These are substantially larger effects than older medications.

Who Is a Candidate for Ozempic for Weight Loss?

Australian GPs typically consider Ozempic or Wegovy for weight management in patients who:

Have a BMI of 30 or above (obesity), or
Have a BMI of 27 or above with a weight-related comorbidity such as hypertension, sleep apnoea, or pre-diabetes
Have not achieved adequate results through lifestyle modification alone
Do not have contraindications (personal or family history of medullary thyroid cancer, MEN2 syndrome, pancreatitis history)

The consultation is where a GP assesses whether pharmacotherapy is appropriate for you specifically. This is not a rubber stamp — it is a genuine clinical evaluation.

What Does Ozempic Cost in Australia?

For weight loss purposes, Ozempic is prescribed as a private prescription — it is not subsidised by the PBS for this indication. Typical costs in 2026:

GP consultation: Bulk billed (Medicare-covered) at clinics offering this service — meaning no out-of-pocket cost for the appointment itself
Ozempic pen (0.5mg or 1mg dose, 4 weeks supply): Approximately $130–$160 at pharmacy
Ozempic pen (2mg dose, 4 weeks supply): Approximately $160–$200 at pharmacy

These are private pharmacy prices and may vary between pharmacies. Compounding pharmacies have offered semaglutide compounds at lower prices, but the TGA has restricted these arrangements — only TGA-registered products (Ozempic and Wegovy) are legally available in Australia.

How Do You Access Ozempic for Weight Loss in Australia?

The pathway is straightforward:

Consult a GP — either in person or via telehealth. No referral to a specialist is needed.
Clinical assessment — the GP reviews your health history, BMI, comorbidities, and determines if a GLP-1 medication is appropriate.
Prescription issued — if appropriate, the GP issues a private script (eScript or paper).
Collect from pharmacy — take the prescription to any Australian pharmacy stocking Ozempic or Wegovy.

Some telehealth services — including Weight Loss GP Australia — offer bulk billed GP consultations for eligible patients, meaning the appointment itself has no out-of-pocket cost.

What Are the Side Effects?

The most common side effects of Ozempic are gastrointestinal:

Nausea (especially in the first few weeks)
Vomiting
Diarrhoea or constipation
Reduced appetite (this is also the therapeutic effect)

Most patients find these effects are worst at the start of treatment and with each dose increase, and improve over time. Starting at the lowest dose (0.25mg) and titrating slowly is standard practice to minimise these effects.

Serious adverse events are rare but include pancreatitis and, in people with a relevant personal or family history, a theoretical risk of thyroid C-cell tumours (seen in animal studies; human relevance is uncertain).

Is Ozempic Right for You?

The honest answer is: only a GP who has reviewed your health history can tell you. This article is general information, not medical advice.

What we can say is that semaglutide (Ozempic/Wegovy) has the strongest evidence base of any currently available pharmacotherapy for weight management in Australia — and that accessing a GP consultation to discuss it has never been easier, or more affordable.